Cancer-fighting Peninsula company postpones $92 million IPO
August 01, 2019 at 15:06 PM EDT
The company has planned for the IPO proceeds to fund clinical trials in experimental cancer and inflammation drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|